Literature DB >> 17126530

Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.

Julien Gagnon1, Sheela Ramanathan, Chantal Leblanc, Subburaj Ilangumaran.   

Abstract

Mice lacking the gene for suppressor of cytokine signaling 1 (SOCS1) show defective homeostasis of T lymphocytes due to accumulation of CD8(+) T cells, resulting at least partly from dysregulated IL-15 signaling. IL-15 alone does not stimulate proliferation of naïve CD8 T cells, but can synergize with IL-21 to induce proliferation, suggesting a potential role for IL-21 in the defective homeostasis of CD8(+) T lymphocytes in SOCS1(-/-) mice. Since IL-21 strongly induced SOCS1 mRNA in CD8(+) T cells, we investigated whether SOCS1 regulates their response to IL-21. CD8(+) T cells isolated from SOCS1-deficient mice proliferated vigorously in response to IL-21+IL-15. In CD8(+) T lymphocytes expressing transgenic TCR, IL-21+IL-7 provided a stronger stimulus to naïve cells whereas IL-15+IL-21 potently stimulated memory cells. Compared to truly naïve or memory cells, SOCS1(-/-) H-Y TCR(+) CD8(+) T cells displayed CD44(lo)Ly6C(hi)CD122(int)CD127(lo) partial memory phenotype and exhibited stronger response to IL-15+IL-21 than truly naïve cells. In SOCS1(-/-) CD8(+) T cells, IL-21 caused greater reduction in IL-15 threshold for activation in a dose-dependent manner. SOCS1 deficiency did not modulate IL-21Ralpha expression or sensitivity to IL-21, but delayed the loss of IL-21-induced phospho-STAT3 signal. These results show that SOCS1 is a critical regulator of IL-21 signaling in CD8(+) T cells, and support the notion that sustained IL-21 signaling might also contribute to the aberrant T cell homeostasis in SOCS1-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126530     DOI: 10.1016/j.cellsig.2006.10.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  16 in total

1.  SOCS1 downregulation in dendritic cells promotes memory T-cell responses.

Authors:  Melissa Aldrich; Denise Sanders; Natasha Lapteva; Xue F Huang; Si-Yi Chen
Journal:  Vaccine       Date:  2007-12-07       Impact factor: 3.641

Review 2.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

3.  Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.

Authors:  Kristan D Guenterberg; Gregory B Lesinski; Bethany L Mundy-Bosse; Volodymyr I Karpa; Alena Cristina Jaime-Ramirez; Lai Wei; William E Carson
Journal:  Cancer Immunol Immunother       Date:  2011-05-21       Impact factor: 6.968

Review 4.  Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus.

Authors:  Jing Li; Hai-Feng Pan; Han Cen; Jing Tian; Yan Ma; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

5.  IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype.

Authors:  Magdalena Huber; Anne Brüstle; Katharina Reinhard; Anna Guralnik; Gina Walter; Azita Mahiny; Eberhard von Löw; Michael Lohoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

Review 6.  Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function.

Authors:  Douglas C Palmer; Nicholas P Restifo
Journal:  Trends Immunol       Date:  2009-10-30       Impact factor: 16.687

7.  Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3.

Authors:  Hayley A Croom; David J Izon; Mark M Chong; David J Curtis; Andrew W Roberts; Thomas W H Kay; Douglas J Hilton; Warren S Alexander; Robyn Starr
Journal:  Mol Immunol       Date:  2008-03-05       Impact factor: 4.407

8.  Selective reduction of post-selection CD8 thymocyte proliferation in IL-15Rα deficient mice.

Authors:  Kai-Ping N Chow; Jian-Tai Qiu; Jam-Mou Lee; Shuo-Lun Hsu; Shan-Che Yang; Ning-Ning Wu; Wei Huang; Tzong-Shoon Wu
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

Review 9.  IL-21: a pleiotropic cytokine with potential applications in oncology.

Authors:  Michela Croce; Valentina Rigo; Silvano Ferrini
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

10.  IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma.

Authors:  Klaus Stensgaard Frederiksen; Dorthe Lundsgaard; Jeremy A Freeman; Steven D Hughes; Thomas L Holm; Birte K Skrumsager; Andreas Petri; Lasse T Hansen; Grant A McArthur; Ian D Davis; Kresten Skak
Journal:  Cancer Immunol Immunother       Date:  2008-02-20       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.